Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma

Figure 10

Survival analysis of PLCB4 (203896_s_at) in NSCLC. (a) Survival analysis of PLCB4 in both adenocarcinoma and squamous cell cancer. (b) Survival analysis of PLCB4 in adenocarcinoma. (c) Survival analysis of PLCB4 in squamous cell cancer. Notes: NSCLC, non-small cell lung carcinoma; PLCB4, phospholipase C beta 4; HR, hazard ratio.

(a)

(b)

(c)